Antiinfectives for treatment of acne

Ilosone

Approved 6 Jan 1975OralFor suspension

The FDA lists this product in 11 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: ERYTHROMYCIN ESTOLATE EQ 125MG BASE/5ML

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

ANDA061897-002 · Discontinued

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA061893.

Open Drugs@FDA

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Ilosone
Active substance: erythromycin estolate
Drug class: Antiinfectives for treatment of acne, Macrolides, Antibiotics
Group: Antibiotics
Route: Oral
Dosage form: For suspension
Applicant: Dista
Status: Discontinued
FDA approval: 6 Jan 1975
Application: ANDA061893-001
RxCUI: 4055

Guidelines

Ciprofloxacin HydrochlorideSolution/drops

Pivyapivmecillinam hydrochloride · Tablet

FidaxomicinTablet

Likmezmetronidazole · Suspension

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloridebismuth subcitrate potassium · Capsule

Voquezna Dual Pakamoxicillin · Capsule, tablet

FexinidazoleTablet

ErythromycinTablet, delayed release

Nuzyraomadacycline tosylate · Powder

Arikayce Kitamikacin sulfate · Suspension, liposomal

Cefepime Hydrochloride in Plastic Containercefepime hydrochloride · Powder

Ertapenem SodiumInjectable

Solosecsecnidazole · Granule

Baxdeladelafloxacin meglumine · Tablet

Moxifloxacin Hydrochloride in Sodium Chloride 0.8% in Plastic Containermoxifloxacin hydrochloride · Solution

Zenavoddoxycycline · Capsule